We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$3.63B
AUM Growth
+$350M
Cap. Flow
+$1.3M
Cap. Flow %
0.04%
Top 10 Hldgs %
33.89%
Holding
638
New
75
Increased
129
Reduced
136
Closed
37

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$29M
2
GWW icon
W.W. Grainger
GWW
+$20.6M
3
ABEV icon
Ambev
ABEV
+$9.79M
4
UL icon
Unilever
UL
+$3.09M
5
WOLF icon
Wolfspeed
WOLF
+$1.82M

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Consumer Staples 14.87%
3 Industrials 12.99%
4 Healthcare 12.98%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBCP icon
301
United Bancorp
UBCP
$89.2M
$125K ﹤0.01%
15,536
BEN icon
302
Franklin Resources
BEN
$17.1B
$124K ﹤0.01%
2,154
+1,179
+121% +$63.6K
HSY icon
303
Hershey
HSY
$37B
$124K ﹤0.01%
1,280
BPL
304
DELISTED
Buckeye Partners, L.P.
BPL
$124K ﹤0.01%
1,741
PHO icon
305
Invesco Water Resources ETF
PHO
$2.06B
$122K ﹤0.01%
+4,640
New +$115K
CPRI icon
306
Capri Holdings
CPRI
$1.77B
$121K ﹤0.01%
+1,485
New +$117K
ROP icon
307
Roper Technologies
ROP
$39.1B
$121K ﹤0.01%
875
-115
-12% -$14.9K
TMO icon
308
Thermo Fisher Scientific
TMO
$223B
$120K ﹤0.01%
1,076
VMW
309
DELISTED
VMware, Inc
VMW
$120K ﹤0.01%
+1,333
New +$110K
ETP
310
DELISTED
Energy Transfer Partners L.p.
ETP
$120K ﹤0.01%
2,100
MTB icon
311
M&T Bank
MTB
$36.6B
$119K ﹤0.01%
1,019
AKAM icon
312
Akamai
AKAM
$17.6B
$118K ﹤0.01%
2,500
MBRG
313
DELISTED
Middleburg Financial Corp
MBRG
$117K ﹤0.01%
6,484
PSX icon
314
Phillips 66
PSX
$90B
$115K ﹤0.01%
1,488
-379
-20% -$25.3K
ULTI
315
DELISTED
Ultimate Software Group Inc
ULTI
$114K ﹤0.01%
745
BXP icon
316
Boston Properties
BXP
$10.8B
$113K ﹤0.01%
1,125
TFCFA
317
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$113K ﹤0.01%
3,215
+890
+38% +$30K
NEM icon
318
Newmont
NEM
$124B
$110K ﹤0.01%
4,790
+822
+21% +$21.1K
VRTX icon
319
Vertex Pharmaceuticals
VRTX
$133B
$110K ﹤0.01%
1,477
+1,177
+392% +$82K
DGX icon
320
Quest Diagnostics
DGX
$26.2B
$109K ﹤0.01%
2,035
MOO icon
321
VanEck Agribusiness ETF
MOO
$974M
$109K ﹤0.01%
2,005
+1,495
+293% +$79.4K
FTI icon
322
TechnipFMC
FTI
$29.5B
$107K ﹤0.01%
+2,761
New +$107K
RWR icon
323
State Street SPDR Dow Jones REIT ETF
RWR
$1.87B
$107K ﹤0.01%
+1,500
New +$110K
LO
324
DELISTED
LORILLARD INC COM STK
LO
$106K ﹤0.01%
2,100
EFOR
325
Everforth Inc
EFOR
$1.34B
$105K ﹤0.01%
3,000

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Loring Wolcott & Coolidge Fiduciary Advisors held 638 positions worth $3.63B, up 11% from $3.28B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2013 filing shows 75 new, 129 increased, 136 reduced and 37 closed positions. Its largest new stake was Ambev: 1,338,605 shares worth $9.84M. The largest sale was Ovintiv, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Industrials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2013 buy was Ambev: 1,338,605 shares worth $9.84M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Warner Bros in Q4 2013, an estimated $29M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2013 reduction was Ovintiv, cutting an estimated $11.9M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $10.5M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 34% of its $3.63B portfolio in Q4 2013.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 75 new positions and closed 37 in Q4 2013.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 11% quarter-over-quarter to $3.63B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2013, filed 11 Feb 2014.